Public Market Listing
2096HKEX
Live quotes, historical charts, and market capitalization for Simcere Pharmaceutical are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(4 total)
4Total Assets
0Approved
3Phase 3 / Filed
1Phase 1–2 / Early
5Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | VEGFR2 (KDR/Flk-1) on vascular endothelial cellsSmall molecule | Non-Small Cell Lung Cancer | |
| Phase 3 | Undisclosed / early pipeline | Rheumatoid Arthritis | |
| Phase 3 | IL-4R-alphaMonoclonal antibody | Atopic DermatitisChronic Obstructive Pulmonary Disease | |
| Phase 1 | GPRC5D x BCMA x CD3Multispecific antibody | Multiple Myeloma |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.